Don't Use a Flozin Plus a GLP-1 Agonist for Most Diabetes Patients

July 2018

Buzz about CV benefits with SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) will spark curiosity about COMBINING them.

You've probably seen the ads...that Jardiance (empagliflozin) or Victoza (liraglutide) reduces both CV risk and death in type 2 diabetes.

This sets them apart from other diabetes meds. For example, so far Invokana (canagliflozin) or Ozempic (semaglutide) only lowers CV risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote